Tianyancha Data: Exposing Companies Involved Behind Exosome Issues

GateUser-bd883c58 · 2026-03-16T04:07:55+00:00

The CCTV 315 Evening Gala exposed issues with "universal" exosomes, with several hospitals under Meile Medical being named. Meile Medical and Beauty Group was established in 2010 with registered capital of 50 million yuan, has multiple investment companies, and some hospitals have previously faced penalties.

GateUser-bd883c58

2026-03-16 04:07:55

Abstract generation in progress

Radar Finance News: The CCTV 315 Gala exposed issues with “all-purpose” exosomes, mentioning Meilai Medical’s Tianjin Hedong Meilai Medical Beauty Hospital Co., Ltd. and Sichuan Huamei Zixin Plastic Surgery Hospital Co., Ltd.

Tianyancha app shows that Meilai Medical Beauty Group Co., Ltd. was established in January 2010. The legal representative is Zhuang Jian, with a registered capital of 50 million RMB. Its business scope includes surgery, plastic surgery, dentistry, and more, jointly held by Shanghai Meilai Investment Management Co., Ltd. and Chen Jinxiu. External investments indicate that the company has invested in 49 enterprises, 38 of which are active, including Jianxinkang Rong Commercial Factoring (Xiamen) Co., Ltd. and Shanghai Meilai Medical Beauty Outpatient Department Co., Ltd. Risk information around the company shows that several subsidiaries, such as Foshan Meilai Medical Beauty Hospital Co., Ltd. and Xiamen Meilai Medical Beauty Outpatient Department Co., Ltd., have been penalized.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes